21.99

3.57% -0.73

Tandem Diabetes Care Inc (TNDM)

Overview News Price History Option Chain Financials Why TNDM Down? Discussions Forecast Stock Split

Tandem Diabetes Care Inc stock is traded at $21.99, with a volume of 781.10K. It is down -3.57% in the last 24 hours and up +28.28% over the past month. Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Previous Close:

$22.72

Open:

$22.5

24h Volume:

781.10K

Relative Volume:

0.34

Market Cap:

$1.53B

Revenue:

$1.03B

Net Income/Loss:

$-94.55M

P/E Ratio:

-15.69

EPS:

-1.4012

Net Cash Flow:

$-3.64M

1W Performance:

-3.95%

1M Performance:

+28.28%

6M Performance:

+16.30%

1Y Performance:

+102.50%

1-Day Range:

$21.70

$22.94

1-Week Range:

$21.70

$23.80

52-Week Range:

$10.25

$29.65

Tandem Diabetes Care Inc Stock (TNDM) Company Profile

Name

Tandem Diabetes Care Inc

Sector

Healthcare (1089)

Industry

Medical Devices (141)

Phone

858-366-6900

Address

12400 HIGH BLUFF DRIVE, San Diego, CA

Employee

2,500

Twitter

@tandemdiabetes

Next Earnings Date

2026-08-06

Latest SEC Filings

TNDM's Discussions on Twitter

Compare TNDM vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TNDM Tandem Diabetes Care Inc	21.99	1.58B	1.03B	-94.55M	-3.64M	-1.4012
ABT Abbott Laboratories	110.14	192.51B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	332.14	130.11B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	90.67	116.83B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	51.52	75.11B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	90.79	52.80B	6.30B	1.07B	1.09B	1.8406

Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-19-26	Upgrade	Truist	Hold → Buy
Mar-17-26	Upgrade	Piper Sandler	Neutral → Overweight
Feb-23-26	Upgrade	Lake Street	Hold → Buy
Feb-20-26	Upgrade	BofA Securities	Underperform → Neutral
Jan-27-26	Resumed	TD Cowen	Buy
Dec-16-25	Upgrade	Robert W. Baird	Neutral → Outperform
Oct-21-25	Resumed	Stifel	Hold
Sep-08-25	Initiated	Oppenheimer	Outperform
Aug-12-25	Upgrade	Citigroup	Sell → Neutral
Aug-07-25	Downgrade	Piper Sandler	Overweight → Neutral
Jul-09-25	Downgrade	Citigroup	Neutral → Sell
Jun-16-25	Initiated	Truist	Hold
Apr-10-25	Initiated	Mizuho	Neutral
Mar-05-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Mar-04-25	Downgrade	Citigroup	Buy → Neutral
Mar-03-25	Downgrade	Wells Fargo	Overweight → Equal Weight
Feb-28-25	Downgrade	Bernstein	Outperform → Mkt Perform
Dec-02-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Nov-06-24	Initiated	Bernstein	Outperform
Oct-04-24	Initiated	Goldman	Neutral
Oct-02-24	Initiated	RBC Capital Mkts	Outperform
Aug-22-24	Initiated	Morgan Stanley	Equal-Weight
Aug-08-24	Initiated	Canaccord Genuity	Buy
May-30-24	Initiated	Redburn Atlantic	Buy
May-22-24	Upgrade	Citigroup	Neutral → Buy
Apr-29-24	Upgrade	Wells Fargo	Equal Weight → Overweight
Apr-25-24	Upgrade	Leerink Partners	Market Perform → Outperform
Mar-26-24	Upgrade	Stifel	Hold → Buy
Aug-04-23	Downgrade	Citigroup	Buy → Neutral
May-05-23	Downgrade	BofA Securities	Neutral → Underperform
Apr-24-23	Downgrade	Raymond James	Outperform → Mkt Perform
Mar-29-23	Initiated	UBS	Neutral
Jan-26-23	Initiated	Wolfe Research	Peer Perform
Nov-15-22	Upgrade	Wells Fargo	Underweight → Equal Weight
Oct-18-22	Initiated	Barclays	Overweight
Oct-12-22	Initiated	Jefferies	Buy
Aug-09-22	Downgrade	Wells Fargo	Overweight → Underweight
Mar-02-22	Resumed	BofA Securities	Neutral
Jan-19-22	Upgrade	Wells Fargo	Equal Weight → Overweight
Jul-21-21	Resumed	Cowen	Outperform
May-25-21	Initiated	Barclays	Underweight
Dec-15-20	Downgrade	Wells Fargo	Overweight → Equal Weight
Aug-20-20	Initiated	Wells Fargo	Overweight
Jul-31-20	Upgrade	Guggenheim	Neutral → Buy
Jul-06-20	Upgrade	Citigroup	Neutral → Buy
Jun-18-20	Reiterated	Raymond James	Outperform
Apr-24-20	Downgrade	SVB Leerink	Outperform → Mkt Perform
Mar-23-20	Downgrade	Guggenheim	Buy → Neutral
Mar-05-20	Initiated	Citigroup	Neutral
Feb-06-20	Initiated	Raymond James	Outperform
Feb-04-20	Downgrade	Robert W. Baird	Outperform → Neutral
Oct-18-19	Initiated	Guggenheim	Buy
Oct-04-19	Upgrade	UBS	Neutral → Buy
May-17-19	Reiterated	BofA/Merrill	Neutral
May-13-19	Initiated	SVB Leerink	Outperform
Mar-08-19	Initiated	BMO Capital Markets	Outperform
Mar-05-19	Reiterated	BofA/Merrill	Neutral
Feb-27-19	Reiterated	Lake Street	Buy
Nov-21-18	Upgrade	Robert W. Baird	Neutral → Outperform
Sep-26-18	Reiterated	Dougherty & Company	Buy
Sep-26-18	Reiterated	Piper Jaffray	Overweight

View All

Tandem Diabetes Care Inc Stock (TNDM) Latest News

Aug 15, 2026

Renaissance Technologies LLC Purchases New Position in Tandem Diabetes Care, Inc. $TNDM - marketbeat.com

Aug 15, 2026

Tandem Diabetes Care (NASDAQ:TNDM) Shares Cross Above 200-Day Moving AverageTime to Sell? - marketbeat.com

Aug 15, 2026

5 Must-Read Analyst Questions From Tandem Diabetes’s Q2 Earnings Call - Yahoo Finance

Aug 15, 2026

Aug 14, 2026